Matt Herper’s piece in Forbes, Flatley’s Law: How One Company Is Creating Medicine’s Genetic Revolution, is a must read. Here’s the conclusion: It’s hard to disagree with him. The cost of sequencing a human being’s DNA is less than one-hundred-thousandth of what it was when Flatley started running Illumina 14 years ago. Illumina is hoping … Continue reading The Intel of sequencing